Tiziana Life Sciences – CEO interview February 3, 2021 – Posted in: Tiziana Life Sciences (TILS), Uncategorized

3rd February, 2021 Tiziana Life Sciences CEO Discusses COVID-19 Trial Data in Exclusive Interview Tiziana Life Sciences plc (NASDAQ:TLSA/LSE:TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, today announced an interview with Dr. Kunwar Shailubhai, CEO and CSO, is now available. In the exclusive interview, Dr. Shailubhai discusses the positive effect of nasally administered Foralumab in COVID-19 mediated pulmonary and systemic inflammation and its potential related…

Continue reading